Literature DB >> 29079202

Selective MALT1 paracaspase inhibition does not block TNF-α production downstream of TLR4 in myeloid cells.

Adeline Unterreiner1, Natacha Stoehr1, Christine Huppertz1, Thomas Calzascia1, Christopher J Farady1, Frédéric Bornancin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29079202     DOI： 10.1016/j.imlet.2017.10.009

Source DB:  PubMed          Journal:  Immunol Lett        ISSN： 0165-2478            Impact factor:   3.685


× No keyword cloud information.
  4 in total

1.  Pharmacological inhibition of MALT1 protease activity suppresses endothelial activation via enhancing MCPIP1 expression.

Authors:  Yong Li; Shengping Huang; Xuan Huang; Xiuzhen Li; Adrian Falcon; Adele Soutar; Frederic Bornancin; Zhisheng Jiang; Hong-Bo Xin; Mingui Fu
Journal:  Cell Signal       Date:  2018-06-18       Impact factor: 4.315

2.  MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative Breast Cancer.

Authors:  Jia-Ying Lloyd Lee; Prasanna Ekambaram; Neil M Carleton; Dong Hu; Linda R Klei; Zongyou Cai; Max I Myers; Nathaniel E Hubel; Lidija Covic; Sameer Agnihotri; Daniel Krappmann; Frédéric Bornancin; Adrian V Lee; Steffi Oesterreich; Linda M McAllister-Lucas; Peter C Lucas
Journal:  Mol Cancer Res       Date:  2022-03-01       Impact factor: 6.333

3.  Malt1 Protease Deficiency in Mice Disrupts Immune Homeostasis at Environmental Barriers and Drives Systemic T Cell-Mediated Autoimmunity.

Authors:  Kea Martin; Ratiba Touil; Yeter Kolb; Grozdan Cvijetic; Kiichi Murakami; Laura Israel; Fernanda Duraes; David Buffet; Anton Glück; Satoru Niwa; Marc Bigaud; Tobias Junt; Natasa Zamurovic; Philip Smith; Kathy D McCoy; Pamela S Ohashi; Frédéric Bornancin; Thomas Calzascia
Journal:  J Immunol       Date:  2019-10-28       Impact factor: 5.422

4.  Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology.

Authors:  Kea Martin; Ursula Junker; Elaine Tritto; Esther Sutter; Tina Rubic-Schneider; Hannah Morgan; Satoru Niwa; Jianping Li; Achim Schlapbach; Dana Walker; Marc Bigaud; Christian Beerli; Amanda Littlewood-Evans; Bettina Rudolph; Marc Laisney; David Ledieu; Karen Beltz; Jean Quancard; Frédéric Bornancin; Natasa Zamurovic Ribrioux; Thomas Calzascia
Journal:  Front Immunol       Date:  2020-04-30       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.